Skip To Main Content
Aileen Grace Arriola on Muck Rack

Aileen Grace Arriola

As seen in: Color Research & Application, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Aileen Grace

Contact Aileen Grace, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

IJMS | Free Full-Text | Improved Graft Function following Desensitization of Anti-AT1R and Autoantibodies in a Heart Transplant Recipient Negative for Donor-Specific Antibodies with Antibody-Mediated Rejection: A Case Report

|
By Kévin Ly, Michiko Taniguchi, Aileen Grace Arriola, Regina Jung
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (2) Issue with article?

The Use of Cytologic Material in Melanoma for PD‐L1 Immunostaining

|
By Gregg A. Staerkel, Eva Bashover, Aileen Grace Arriola, Cicily T Joseph
| Color Research & Application Verified
Interest in immune therapies has exploded since the 2014 approval of first generation programed cell death 1 (PD‐1) blocking antibodies for use in advanced melanoma. Clinical trials have focused primarily on histologic material as the gold standard for evaluating PD‐L1 by immunoperoxidase (IPOX) studies. Studies validating the use of cytologic specimens in the assessment of PD‐L1 by IPOX staining are needed to optimize tissue utilization in complementary diagnostic testing.
Open in Who Shared Issue with article?

The use of cytological material in melanoma for programmed death ligand 1 immunostaining

|
By Eva Bashover, Aileen Grace Arriola, Cicily T Joseph, Gregg A. Staerkel
| Color Research & Application Verified
Interest in immune therapies has exploded since the 2014 approval of first‐generation programmed cell death 1 blocking antibodies for use in advanced melanoma. Clinical trials have focused primarily on histological material as the gold standard for evaluating programmed death ligand 1 (PD‐L1) by immunoperoxidase (IPOX) studies.
Open in Who Shared Issue with article?
See all 3 articles